Metabolic remodeling associated with subchronic doxorubicin cardiomyopathy
Authors:
- Rui A. CarvalhoRCRui A. Carvalho
- Rui P.B. SousaRSRui P.B. Sousa
- Virgilio J.J. CadeteVCVirgilio J.J. Cadete
- Gary D. LopaschukGLGary D. Lopaschuk
- Carlos M.M. PalmeiraCarlos M.M. Palmeira
- James A. BjorkJBJames A. Bjork
- Kendall B. WallaceKWKendall B. Wallace
- 1 April 2010
- journal article
- Published by Elsevier in Toxicology
- Vol. 270 (2-3) , 92-98
Abstract
No abstract availableKeywords
This publication has 35 references indexed in Scilit:
- Persistent Alterations to the Gene Expression Profile of the Heart Subsequent to Chronic Doxorubicin TreatmentCardiovascular Toxicology, 2007
- Adriamycin-induced interference with cardiac mitochondrial calcium homeostasisCardiovascular Toxicology, 2007
- Adriamycin-induced oxidative mitochondrial cardiotoxicityCell Biology and Toxicology, 2006
- Carvedilol Protects against Doxorubicin-Induced Mitochondrial CardiomyopathyToxicology and Applied Pharmacology, 2002
- Interference with Calcium-Dependent Mitochondrial Bioenergetics in Cardiac Myocytes Isolated from Doxorubicin-Treated RatsToxicology and Applied Pharmacology, 2001
- REVERSAL OF DOXORUBICIN-INDUCED CARDIAC METABOLIC DAMAGE BYL-CARNITINEPharmacological Research, 1999
- Acute and Chronic Effects of Adriamycin on Fatty Acid Oxidation in Isolated Cardiac MyocytesJournal of Molecular and Cellular Cardiology, 1997
- Characterization of 5′AMP-activated protein kinase activity in the heart and its role in inhibiting acetyl-CoA carboxylase during reperfusion following ischemiaBiochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism, 1996
- Disruption of Mitochondrial Calcium Homeostasis Following Chronic Doxorubicin AdministrationToxicology and Applied Pharmacology, 1994
- Hepatic and cardiac carnitine palmitoyltransferase activityBiochemical Pharmacology, 1987